Yilmaz, Aylin
Fuchs, Dietmar
Price, Richard W.
Spudich, Serena
Blennow, Kaj
Zetterberg, Henrik
Gisslén, Magnus
Funding for this research was provided by:
University of Gothenburg
Article History
First Online: 16 January 2019
Compliance with Ethical Standards
:
: Aylin Yilmaz, Dietmar Fuchs, Serena Spudich, and Richard W. Price declare that they have no conflict of interest. Henrik Zetterberg has served at scientific advisory boards for Eli Lilly, Roche Diagnostics and Wave, has received travel support from Teva, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. Kaj Blennow has served as a consultant or at advisory boards for Alzheon, BioArctic, Biogen, Eli Lilly, IBL International, Merck, Novartis, Pfizer, and Roche Diagnostics, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg.
: The study was approved by the regional ethics committees and informed consent was obtained from the participants. No animal experiments were performed.